Prelude Capital Management’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-677
| Closed | -$45.7K | – | 1064 |
|
|
2023
Q2 | $45.7K | Buy |
+677
| New | +$45.7K | ﹤0.01% | 860 |
|
|
2021
Q4 | – | Sell |
-596
| Closed | -$152K | – | 1689 |
|
|
2021
Q3 | $152K | Buy |
596
+144
| +32% | +$36.7K | ﹤0.01% | 1086 |
|
|
2021
Q2 | $301K | Buy |
+452
| New | +$301K | 0.01% | 958 |
|
|
2020
Q4 | – | Sell |
-98
| Closed | -$100K | – | 1034 |
|
|
2020
Q3 | $100K | Sell |
98
-78
| -44% | -$79.6K | ﹤0.01% | 680 |
|
|
2020
Q2 | $178K | Buy |
+176
| New | +$178K | 0.01% | 524 |
|
|
2020
Q1 | – | Sell |
-27
| Closed | -$29K | – | 1127 |
|
|
2019
Q4 | $29K | Buy |
27
+25
| +1,250% | +$26.9K | ﹤0.01% | 1086 |
|
|
2019
Q3 | $2K | Buy |
+2
| New | +$2K | ﹤0.01% | 1111 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 1388 |
|
|
2019
Q1 | – | Sell |
-167
| Closed | -$193K | – | 1474 |
|
|
2018
Q4 | $193K | Buy |
+167
| New | +$193K | 0.01% | 515 |
|
|
2018
Q3 | – | Sell |
-42
| Closed | -$65K | – | 1449 |
|
|
2018
Q2 | $65K | Buy |
+42
| New | +$65K | ﹤0.01% | 832 |
|
|
2018
Q1 | – | Sell |
-69
| Closed | -$82K | – | 1412 |
|
|
2017
Q4 | $82K | Sell |
69
-20
| -22% | -$23.8K | 0.01% | 740 |
|
|
2017
Q3 | $120K | Buy |
+89
| New | +$120K | 0.01% | 754 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 1563 |
|
|
2016
Q3 | – | Sell |
-184
| Closed | -$75K | – | 1581 |
|
|
2016
Q2 | $75K | Buy |
184
+60
| +48% | +$24.5K | 0.01% | 814 |
|
|
2016
Q1 | $66K | Buy |
124
+24
| +24% | +$12.8K | 0.01% | 818 |
|
|
2015
Q4 | $76K | Buy |
+100
| New | +$76K | 0.01% | 852 |
|